Cancer Biological Therapy Market Size By Product, By Route of Administration, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023

Description

List of Tables

Cancer Biological Therapy Market is poised to gain substantial traction through 2032, primarily owing to the growing geriatric population, since old age is one of the major risk factors for cancer. For instance, as per studies, while on average there are just 25 cases of cancer per 100,000 people who are under 20, this number rises to a whopping 1000 for 100,000 people when the age cap is more than 60 years.

Besides, the key providers in the cancer biological therapy market are also seeking a better foothold in the marketplace by expanding their portfolio, in addition to engaging in meaningful mergers, acquisitions, and joint ventures. To cite an instance, in December 2022, Genetech received FDA approval for Lunsumio, which can be used to treat refractory and relapsed follicular lymphoma. As per reports, Lunsumio is the first CD20xCD3 T-cell engaging bispecific antibody, which is a new kind of cancer immunotherapy.

Overall, the cancer biological therapy market has been segmented in terms of product, route of administration, and region.

On the basis of product, the market is likely to be characterized by the cancer growth blockers segment, which will grow at more than 6.5% CAGR during 2023 and 2032. The expansion can be attributed to the increasing demand for new cancer treatments. Besides, the development of more effective blockers and increasing R&D projects will also foster the market demand over the foreseeable period.

In terms of route of administration, the injectable segment is set to witness significant growth within the next ten years, due to the increasing adoption of antibodies-based cancer treatment. Besides, there have been constant clinical trials and R&D in this niche, which has added more options for injectable drugs. For instance, in May 2021, research titled, "Antibody-based cancer therapy" claimed that in the United States, cancer patients can opt for 43 different antibody therapeutics, out of which more than half have become available, only in the last 5 years.

In the regional context, the North America cancer biological therapy market held more than 40.5% market share in 2022 and is anticipated to further expand by 2032 end. This growth can be attributed to the increasing cases of cancer in North American region. As per reports, in 2022, the USA witnessed 1.9 million cancer cases and more than 600,000 deaths. Besides, rising adoption of a sedentary lifestyle, drug and alcohol abuse, and unhealthy dietary habits will also benefit the market over the next decade.

Product Code: 676

Chapter 1 Methodology & Scope

1.1 Methodology
1.2 Market scope and definition
1.3 Base estimates and working
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Cancer biological therapy market industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Route of administration trends
- 2.1.4 Regional trends

Chapter 3 Cancer Biological Therapy Industry Insights

3.1 Industry landscape, 2018 - 2032
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing incidence of cancer worldwide
  - 3.2.1.2 Growing geriatric population
  - 3.2.1.3 Technological advancement in cancer biologics in developed countries
  - 3.2.1.4 Increasing R&D funding coupled with favorable government policies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of treatment
  - 3.2.2.2 Adverse effects of anti-cancer drug therapy
3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By route of administration
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
- 3.5.1 U.S.
- 3.5.2 Europe
3.6 Pricing analysis
3.7 Pipeline analysis
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company market share analysis, 2022
4.3 Company matrix analysis, 2022
4.4 Competitive positioning matrix
4.5 Strategy dashboard, 2021

Chapter 5 Cancer Biological Therapy Market, By Product

5.1 Key product trends
5.2 Monoclonal antibodies (MAB)
- 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.2.2 Naked MAB
  - 5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.2.3 Conjugated MAB
  - 5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.2.4 Bispecific MAB
  - 5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Vaccines
- 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.3.2 Preventive vaccines
  - 5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.3.3 Therapeutic vaccines
  - 5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Cancer growth blockers
- 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.4.2 Tyrosine kinase Inhibitors (TKI)
  - 5.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.4.3 Proteasome Inhibitors (PI)
  - 5.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.4.4 mTOR Inhibitors
  - 5.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5 Blood cell growth factors (BCGF)
- 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.5.2 Lenograstim
  - 5.5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.5.3 Filgrastim
  - 5.5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6 Cytokines
- 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.6.2 Interferons
  - 5.6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.6.3 Interleukins
  - 5.6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Cancer Biological Therapy Market, By Route of administration

6.1 Key route of administration trends
6.2 Oral
- 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Injectable
- 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Cancer Biological Therapy Market, By Region

7.1 Key regional trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Poland
- 7.3.7 Switzerland
- 7.3.8 Netherlands
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Indonesia
- 7.4.7 Thailand
- 7.4.8 Vietnam
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Argentina
- 7.5.3 Mexico
- 7.5.4 Chile
- 7.5.5 Columbia
- 7.5.6 Peru
7.6 Middle East & Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Egypt
- 7.6.5 Iran

Chapter 8 Company Profiles

8.1 AbbVie Inc.
8.2 Amgen Inc.
8.3 Astellas Pharma Inc.
8.4 AstraZeneca
8.5 Bayer AG
8.6 Bristol-Myers Squibb Company
8.7 Eisai Co., Ltd.
8.8 Eli Lilly and Company
8.9 F. Hoffmann-La Roche
8.10 GlaxoSmithKline plc
8.11 Incyte
8.12 Merck
8.13 Novartis
8.14 Otsuka
8.15 Pfizer
8.16 Sanofi
8.17 Seattle Genetics
8.18 Spectrum Pharmaceuticals
8.19 Takeda Pharmaceuticals

Data Tables

TABLE 1. Global cancer biological therapy market, 2018 - 2022, (USD Million)
TABLE 2. Global cancer biological therapy market, 2023 - 2032, (USD Million)
TABLE 3. Global cancer biological therapy market, by product, 2018 - 2022 (USD Million)
TABLE 4. Global cancer biological therapy market, by product, 2023 - 2032, (USD Million)
TABLE 5. Global cancer biological therapy market, by route of administration, 2018 - 2022 (USD Million)
TABLE 6. Global cancer biological therapy market, by route of administration, 2023 - 2032, (USD Million)
TABLE 7. Global cancer biological therapy market, by region, 2018 - 2022 (USD Million)
TABLE 8. Global cancer biological therapy market, by region, 2023 - 2032 (USD Million)
TABLE 9. Industry impact forces
TABLE 10. Monoclonal antibodies (MAB) market, 2018 - 2022, (USD Million)
TABLE 11. Monoclonal antibodies (MAB) market, 2023 - 2032 (USD Million)
TABLE 12. Naked MAB market, 2018 - 2022 (USD Million)
TABLE 13. Naked MAB market, 2023 - 2032 (USD Million)
TABLE 14. Conjugated MAB market, 2018 - 2022 (USD Million)
TABLE 15. Conjugated MAB market, 2023 - 2032 (USD Million)
TABLE 16. Bi specific MAB market, 2018 - 2022 (USD Million)
TABLE 17. Bi specific MAB market, 2023 - 2032 (USD Million)
TABLE 18. Vaccines market, 2018 - 2022 (USD Million)
TABLE 19. Vaccines market, 2023 - 2032 (USD Million)
TABLE 20. Preventive vaccines market, 2018 - 2022 (USD Million)
TABLE 21. Preventive vaccines market, 2023 - 2032 (USD Million)
TABLE 22. Therapeutic vaccines market, 2018 - 2022 (USD Million)
TABLE 23. Therapeutic vaccines market, 2023 - 2032 (USD Million)
TABLE 24. Cancer growth blockers market, 2018 - 2022 (USD Million)
TABLE 25. Cancer growth blockers market, 2023 - 2032 (USD Million)
TABLE 26. TKI market, 2018 - 2022 (USD Million)
TABLE 27. TKI market, 2023 - 2032 (USD Million)
TABLE 28. PI market, 2018 - 2022 (USD Million)
TABLE 29. PI market, 2023 - 2032 (USD Million)
TABLE 30. mTOR Inhibitors market, 2018 - 2022 (USD Million)
TABLE 31. mTOR Inhibitors market, 2023 - 2032 (USD Million)
TABLE 32. Blood cell growth factors market, 2018 - 2022, (USD Million)
TABLE 33. Blood cell growth factors market, 2023 - 2032 (USD Million)
TABLE 34. Lenograstim market, 2018 - 2022 (USD Million)
TABLE 35. Lenograstim market, 2023 - 2032 (USD Million)
TABLE 36. Filgrastim market, 2018 - 2022 (USD Million)
TABLE 37. Filgrastim market, 2023 - 2032 (USD Million)
TABLE 38. Cytokine market, 2018 - 2022, (USD Million)
TABLE 39. Cytokine market, 2023 - 2032, (USD Million)
TABLE 40. Interferons market, 2018 - 2022 (USD Million)
TABLE 41. Interferons market, 2023 - 2032 (USD Million)
TABLE 42. Interleukins market, 2018 - 2022 (USD Million)
TABLE 43. Interleukins market, 2023 - 2032 (USD Million
TABLE 44. Oral market, 2018 - 2022, (USD Million)
TABLE 45. Oral market, 2023 - 2032, (USD Million)
TABLE 46. Injectable market, 2018 - 2022, (USD Million)
TABLE 47. Injectable market, 2023 - 2032, (USD Million)
TABLE 48. North America cancer biological therapy market size, by country, 2018 - 2022 (USD Million)
TABLE 49. North America cancer biological therapy market size, by country, 2023 - 2032, (USD Million)
TABLE 50. North America cancer biological therapy market size, by product, 2018 - 2022 (USD Million)
TABLE 51. North America cancer biological therapy market size, by product, 2023 - 2032, (USD Million)
TABLE 52. North America cancer biological therapy market size, by MAB, 2018 - 2022 (USD Million)
TABLE 53. North America cancer biological therapy market size, by MAB, 2023 - 2032 (USD Million)
TABLE 54. North America cancer biological therapy market size, by vaccines, 2018 - 2022 (USD Million)
TABLE 55. North America cancer biological therapy market size, by vaccines, 2023 - 2032 (USD Million)
TABLE 56. North America cancer biological therapy market size, by cancer growth blockers, 2018 - 2022 (USD Million)
TABLE 57. North America cancer biological therapy market size, by cancer growth blockers, 2023 - 2032 (USD Million)
TABLE 58. North America cancer biological therapy market size, by blood cell growth factors, 2018 - 2022 (USD Million)
TABLE 59. North America cancer biological therapy market size, by blood cell growth factors, 2023 - 2032 (USD Million)
TABLE 60. North America cancer biological therapy market size, by cytokines, 2018 - 2022 (USD Million)
TABLE 61. North America cancer biological therapy market size, by cytokines, 2023 - 2032 (USD Million)
TABLE 62. North America cancer biological therapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 63. North America cancer biological therapy market size, by route of administration, 2023 - 2032, (USD Million)
TABLE 64. U.S. cancer biological therapy market size, by product, 2018 - 2022 (USD Million)
TABLE 65. U.S. cancer biological therapy market size, by product, 2023 - 2032, (USD Million)
TABLE 66. U.S. cancer biological therapy market size, by MAB, 2018 - 2022 (USD Million)
TABLE 67. U.S. cancer biological therapy market size, by MAB, 2023 - 2032 (USD Million)
TABLE 68. U.S. cancer biological therapy market size, by vaccines, 2018 - 2022 (USD Million)
TABLE 69. U.S. cancer biological therapy market size, by vaccines, 2023 - 2032 (USD Million)
TABLE 70. U.S. cancer biological therapy market size, by cancer growth blockers, 2018 - 2022 (USD Million)
TABLE 71. U.S. cancer biological therapy market size, by cancer growth blockers, 2023 - 2032 (USD Million)
TABLE 72. U.S. cancer biological therapy market size, by blood cell growth factors, 2018 - 2022 (USD Million)
TABLE 73. U.S. cancer biological therapy market size, by blood cell growth factors, 2023 - 2032 (USD Million)
TABLE 74. U.S. cancer biological therapy market size, by cytokines, 2018 - 2022 (USD Million)
TABLE 75. U.S. cancer biological therapy market size, by cytokines, 2023 - 2032 (USD Million)
TABLE 76. U.S. cancer biological therapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 77. U.S. cancer biological therapy market size, by route of administration, 2023 - 2032, (USD Million)
TABLE 78. Canada cancer biological therapy market size, by product, 2018 - 2022 (USD Million)
TABLE 79. Canada cancer biological therapy market size, by product, 2023 - 2032, (USD Million)
TABLE 80. Canada cancer biological therapy market size, by MAB, 2018 - 2022 (USD Million)
TABLE 81. Canada cancer biological therapy market size, by MAB, 2023 - 2032 (USD Million)
TABLE 82. Canada cancer biological therapy market size, by vaccines, 2018 - 2022 (USD Million)
TABLE 83. Canada cancer biological therapy market size, by vaccines, 2023 - 2032 (USD Million)
TABLE 84. Canada cancer biological therapy market size, by cancer growth blockers, 2018 - 2022 (USD Million)
TABLE 85. Canada cancer biological therapy market size, by cancer growth blockers, 2023 - 2032 (USD Million)
TABLE 86. Canada cancer biological therapy market size, by blood cell growth factors, 2018 - 2022 (USD Million)
TABLE 87. Canada cancer biological therapy market size, by blood cell growth factors, 2023 - 2032 (USD Million)
TABLE 88. Canada cancer biological therapy market size, by cytokines, 2018 - 2022 (USD Million)
TABLE 89. Canada cancer biological therapy market size, by cytokines, 2023 - 2032 (USD Million)
TABLE 90. Canada cancer biological therapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 91. Canada cancer biological therapy market size, by route of administration, 2023 - 2032, (USD Million)
TABLE 92. Europe cancer biological therapy market size, by country, 2018 - 2022 (USD Million)
TABLE 93. Europe cancer biological therapy market size, by country, 2023 - 2032, (USD Million)
TABLE 94. Europe cancer biological therapy market size, by product, 2018 - 2022 (USD Million)
TABLE 95. Europe cancer biological therapy market size, by product, 2023 - 2032, (USD Million)
TABLE 96. Europe cancer biological therapy market size, by MAB, 2018 - 2022 (USD Million)
TABLE 97. Europe cancer biological therapy market size, by MAB, 2023 - 2032 (USD Million)
TABLE 98. Europe cancer biological therapy market size, by vaccines, 2018 - 2022 (USD Million)
TABLE 99. Europe cancer biological therapy market size, by vaccines, 2023 - 2032 (USD Million)
TABLE 100. Europe cancer biological therapy market size, by cancer growth blockers, 2018 - 2022 (USD Million)
TABLE 101. Europe cancer biological therapy market size, by cancer growth blockers, 2023 - 2032 (USD Million)
TABLE 102. Europe cancer biological therapy market size, by blood cell growth factors, 2018 - 2022 (USD Million)
TABLE 103. Europe cancer biological therapy market size, by blood cell growth factors, 2023 - 2032 (USD Million)
TABLE 104. Europe cancer biological therapy market size, by cytokines, 2018 - 2022 (USD Million)
TABLE 105. Europe cancer biological therapy market size, by cytokines, 2023 - 2032 (USD Million)
TABLE 106. Europe cancer biological therapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 107. Europe cancer biological therapy market size, by route of administration, 2023 - 2032, (USD Million)
TABLE 108. Germany cancer biological therapy market size, by product, 2018 - 2022 (USD Million)
TABLE 109. Germany cancer biological therapy market size, by product, 2023 - 2032, (USD Million)
TABLE 110. Germany cancer biological therapy market size, by MAB, 2018 - 2022 (USD Million)
TABLE 111. Germany cancer biological therapy market size, by MAB, 2023 - 2032 (USD Million)
TABLE 112. Germany cancer biological therapy market size, by vaccines, 2018 - 2022 (USD Million)
TABLE 113. Germany cancer biological therapy market size, by vaccines, 2023 - 2032 (USD Million)
TABLE 114. Germany cancer biological therapy market size, by cancer growth blockers, 2018 - 2022 (USD Million)
TABLE 115. Germany cancer biological therapy market size, by cancer growth blockers, 2023 - 2032 (USD Million)
TABLE 116. Germany cancer biological therapy market size, by blood cell growth factors, 2018 - 2022 (USD Million)
TABLE 117. Germany cancer biological therapy market size, by blood cell growth factors, 2023 - 2032 (USD Million)
TABLE 118. Germany cancer biological therapy market size, by cytokines, 2018 - 2022 (USD Million)
TABLE 119. Germany cancer biological therapy market size, by cytokines, 2023 - 2032 (USD Million)
TABLE 120. Germany cancer biological therapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 121. Germany cancer biological therapy market size, by route of administration, 2023 - 2032, (USD Million)
TABLE 122. UK cancer biological therapy market size, by product, 2018 - 2022 (USD Million)
TABLE 123. UK cancer biological therapy market size, by product, 2023 - 2032, (USD Million)
TABLE 124. UK cancer biological therapy market size, by MAB, 2018 - 2022 (USD Million)
TABLE 125. UK cancer biological therapy market size, by MAB, 2023 - 2032 (USD Million)
TABLE 126. UK cancer biological therapy market size, by vaccines, 2018 - 2022 (USD Million)
TABLE 127. UK cancer biological therapy market size, by vaccines, 2023 - 2032 (USD Million)
TABLE 128. UK cancer biological therapy market size, by cancer growth blockers, 2018 - 2022 (USD Million)
TABLE 129. UK cancer biological therapy market size, by cancer growth blockers, 2023 - 2032 (USD Million)
TABLE 130. UK cancer biological therapy market size, by blood cell growth factors, 2018 - 2022 (USD Million)
TABLE 131. UK cancer biological therapy market size, by blood cell growth factors, 2023 - 2032 (USD Million)
TABLE 132. UK cancer biological therapy market size, by cytokines, 2018 - 2022 (USD Million)
TABLE 133. UK cancer biological therapy market size, by cytokines, 2023 - 2032 (USD Million)
TABLE 134. UK cancer biological therapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 135. UK cancer biological therapy market size, by route of administration, 2023 - 2032, (USD Million)
TABLE 136. France cancer biological therapy market size, by product, 2018 - 2022 (USD Million)
TABLE 137. France cancer biological therapy market size, by product, 2023 - 2032, (USD Million)
TABLE 138. France cancer biological therapy market size, by MAB, 2018 - 2022 (USD Million)
TABLE 139. France cancer biological therapy market size, by MAB, 2023 - 2032 (USD Million)
TABLE 140. France cancer biological therapy market size, by vaccines, 2018 - 2022 (USD Million)
TABLE 141. France cancer biological therapy market size, by vaccines, 2023 - 2032 (USD Million)
TABLE 142. France cancer biological therapy market size, by cancer growth blockers, 2018 - 2022 (USD Million)
TABLE 143. France cancer biological therapy market size, by cancer growth blockers, 2023 - 2032 (USD Million)
TABLE 144. France cancer biological therapy market size, by blood cell growth factors, 2018 - 2022 (USD Million)
TABLE 145. France cancer biological therapy market size, by blood cell growth factors, 2023 - 2032 (USD Million)
TABLE 146. France cancer biological therapy market size, by cytokines, 2018 - 2022 (USD Million)
TABLE 147. France cancer biological therapy market size, by cytokines, 2023 - 2032 (USD Million)
TABLE 148. France cancer biological therapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 149. France cancer biological therapy market size, by route of administration, 2023 - 2032, (USD Million)
TABLE 150. Italy cancer biological therapy market size, by product, 2018 - 2022 (USD Million)
TABLE 151. Italy cancer biological therapy market size, by product, 2023 - 2032, (USD Million)
TABLE 152. Italy cancer biological therapy market size, by MAB, 2018 - 2022 (USD Million)
TABLE 153. Italy cancer biological therapy market size, by MAB, 2023 - 2032 (USD Million)
TABLE 154. Italy cancer biological therapy market size, by vaccines, 2018 - 2022 (USD Million)
TABLE 155. Italy cancer biological therapy market size, by vaccines, 2023 - 2032 (USD Million)
TABLE 156. Italy cancer biological therapy market size, by cancer growth blockers, 2018 - 2022 (USD Million)
TABLE 157. Italy cancer biological therapy market size, by cancer growth blockers, 2023 - 2032 (USD Million)
TABLE 158. Italy cancer biological therapy market size, by blood cell growth factors, 2018 - 2022 (USD Million)
TABLE 159. Italy cancer biological therapy market size, by blood cell growth factors, 2023 - 2032 (USD Million)
TABLE 160. Italy cancer biological therapy market size, by cytokines, 2018 - 2022 (USD Million)
TABLE 161. Italy cancer biological therapy market size, by cytokines, 2023 - 2032 (USD Million)
TABLE 162. Italy cancer biological therapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 163. Italy cancer biological therapy market size, by route of administration, 2023 - 2032, (USD Million)
TABLE 164. Spain cancer biological therapy market size, by product, 2018 - 2022 (USD Million)
TABLE 165. Spain cancer biological therapy market size, by product, 2023 - 2032, (USD Million)
TABLE 166. Spain cancer biological therapy market size, by MAB, 2018 - 2022 (USD Million)
TABLE 167. Spain cancer biological therapy market size, by MAB, 2023 - 2032 (USD Million)
TABLE 168. Spain cancer biological therapy market size, by vaccines, 2018 - 2022 (USD Million)
TABLE 169. Spain cancer biological therapy market size, by vaccines, 2023 - 2032 (USD Million)
TABLE 170. Spain cancer biological therapy market size, by cancer growth blockers, 2018 - 2022 (USD Million)
TABLE 171. Spain cancer biological therapy market size, by cancer growth blockers, 2023 - 2032 (USD Million)
TABLE 172. Spain cancer biological therapy market size, by blood cell growth factors, 2018 - 2022 (USD Million)
TABLE 173. Spain cancer biological therapy market size, by blood cell growth factors, 2023 - 2032 (USD Million)
TABLE 174. Spain cancer biological therapy market size, by cytokines, 2018 - 2022 (USD Million)
TABLE 175. Spain cancer biological therapy market size, by cytokines, 2023 - 2032 (USD Million)
TABLE 176. Spain cancer biological therapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 177. Spain cancer biological therapy market size, by route of administration, 2023 - 2032, (USD Million)
TABLE 178. Poland cancer biological therapy market size, by product, 2018 - 2022 (USD Million)
TABLE 179. Poland cancer biological therapy market size, by product, 2023 - 2032, (USD Million)
TABLE 180. Poland cancer biological therapy market size, by MAB, 2018 - 2022 (USD Million)
TABLE 181. Poland cancer biological therapy market size, by MAB, 2023 - 2032 (USD Million)
TABLE 182. Poland cancer biological therapy market size, by vaccines, 2018 - 2022 (USD Million)
TABLE 183. Poland cancer biological therapy market size, by vaccines, 2023 - 2032 (USD Million)
TABLE 184. Poland cancer biological therapy market size, by cancer growth blockers, 2018 - 2022 (USD Million)
TABLE 185. Poland cancer biological therapy market size, by cancer growth blockers, 2023 - 2032 (USD Million)
TABLE 186. Poland cancer biological therapy market size, by blood cell growth factors, 2018 - 2022 (USD Million)
TABLE 187. Poland cancer biological therapy market size, by blood cell growth factors, 2023 - 2032 (USD Million)
TABLE 188. Poland cancer biological therapy market size, by cytokines, 2018 - 2022 (USD Million)
TABLE 189. Poland cancer biological therapy market size, by cytokines, 2023 - 2032 (USD Million)
TABLE 190. Poland cancer biological therapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 191. Poland cancer biological therapy market size, by route of administration, 2023 - 2032, (USD Million)
TABLE 192. Switzerland cancer biological therapy market size, by product, 2018 - 2022 (USD Million)
TABLE 193. Switzerland cancer biological therapy market size, by product, 2023 - 2032, (USD Million)
TABLE 194. Switzerland cancer biological therapy market size, by MAB, 2018 - 2022 (USD Million)
TABLE 195. Switzerland cancer biological therapy market size, by MAB, 2023 - 2032 (USD Million)
TABLE 196. Switzerland cancer biological therapy market size, by vaccines, 2018 - 2022 (USD Million)
TABLE 197. Switzerland cancer biological therapy market size, by vaccines, 2023 - 2032 (USD Million)
TABLE 198. Switzerland cancer biological therapy market size, by cancer growth blockers, 2018 - 2022 (USD Million)
TABLE 199. Switzerland cancer biological therapy market size, by cancer growth blockers, 2023 - 2032 (USD Million)
TABLE 200. Switzerland cancer biological therapy market size, by blood cell growth factors, 2018 - 2022 (USD Million)
TABLE 201. Switzerland cancer biological therapy market size, by blood cell growth factors, 2023 - 2032 (USD Million)
TABLE 202. Switzerland cancer biological therapy market size, by cytokines, 2018 - 2022 (USD Million)
TABLE 203. Switzerland cancer biological therapy market size, by cytokines, 2023 - 2032 (USD Million)
TABLE 204. Switzerland cancer biological therapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 205. Switzerland cancer biological therapy market size, by route of administration, 2023 - 2032, (USD Million)
TABLE 206. Netherlands cancer biological therapy market size, by product, 2018 - 2022 (USD Million)
TABLE 207. Netherlands cancer biological therapy market size, by product, 2023 - 2032, (USD Million)
TABLE 208. Netherlands cancer biological therapy market size, by MAB, 2018 - 2022 (USD Million)
TABLE 209. Netherlands cancer biological therapy market size, by MAB, 2023 - 2032 (USD Million)
TABLE 210. Netherlands cancer biological therapy market size, by vaccines, 2018 - 2022 (USD Million)
TABLE 211. Netherlands cancer biological therapy market size, by vaccines, 2023 - 2032 (USD Million)
TABLE 212. Netherlands cancer biological therapy market size, by cancer growth blockers, 2018 - 2022 (USD Million)
TABLE 213. Netherlands cancer biological therapy market size, by cancer growth blockers, 2023 - 2032 (USD Million)
TABLE 214. Netherlands cancer biological therapy market size, by blood cell growth factors, 2018 - 2022 (USD Million)
TABLE 215. Netherlands cancer biological therapy market size, by blood cell growth factors, 2023 - 2032 (USD Million)
TABLE 216. Netherlands cancer biological therapy market size, by cytokines, 2018 - 2022 (USD Million)
TABLE 217. Netherlands cancer biological therapy market size, by cytokines, 2023 - 2032 (USD Million)
TABLE 218. Netherlands cancer biological therapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 219. Netherlands cancer biological therapy market size, by route of administration, 2023 - 2032, (USD Million)
TABLE 220. Asia Pacific cancer biological therapy market size, by country, 2018 - 2022 (USD Million)
TABLE 221. Asia Pacific cancer biological therapy market size, by country, 2023 - 2032, (USD Million)
TABLE 222. Asia Pacific cancer biological therapy market size, by product, 2018 - 2022 (USD Million)
TABLE 223. Asia Pacific cancer biological therapy market size, by product, 2023 - 2032, (USD Million)
TABLE 224. Asia Pacific cancer biological therapy market size, by MAB, 2018 - 2022 (USD Million)
TABLE 225. Asia Pacific cancer biological therapy market size, by MAB, 2023 - 2032 (USD Million)
TABLE 226. Asia Pacific cancer biological therapy market size, by vaccines, 2018 - 2022 (USD Million)
TABLE 227. Asia Pacific cancer biological therapy market size, by vaccines, 2023 - 2032 (USD Million)
TABLE 228. Asia Pacific cancer biological therapy market size, by cancer growth blockers, 2018 - 2022 (USD Million)
TABLE 229. Asia Pacific cancer biological therapy market size, by cancer growth blockers, 2023 - 2032 (USD Million)
TABLE 230. Asia Pacific cancer biological therapy market size, by blood cell growth factors, 2018 - 2022 (USD Million)
TABLE 231. Asia Pacific cancer biological therapy market size, by blood cell growth factors, 2023 - 2032 (USD Million)
TABLE 232. Asia Pacific cancer biological therapy market size, by cytokines, 2018 - 2022 (USD Million)
TABLE 233. Asia Pacific cancer biological therapy market size, by cytokines, 2023 - 2032 (USD Million)
TABLE 234. Asia Pacific cancer biological therapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 235. Asia Pacific cancer biological therapy market size, by route of administration, 2023 - 2032, (USD Million)
TABLE 236. Japan cancer biological therapy market size, by product, 2018 - 2022 (USD Million)
TABLE 237. Japan cancer biological therapy market size, by product, 2023 - 2032, (USD Million)
TABLE 238. Japan cancer biological therapy market size, by MAB, 2018 - 2022 (USD Million)
TABLE 239. Japan cancer biological therapy market size, by MAB, 2023 - 2032 (USD Million)
TABLE 240. Japan cancer biological therapy market size, by vaccines, 2018 - 2022 (USD Million)
TABLE 241. Japan cancer biological therapy market size, by vaccines, 2023 - 2032 (USD Million)
TABLE 242. Japan cancer biological therapy market size, by cancer growth blockers, 2018 - 2022 (USD Million)
TABLE 243. Japan cancer biological therapy market size, by cancer growth blockers, 2023 - 2032 (USD Million)
TABLE 244. Japan cancer biological therapy market size, by blood cell growth factors, 2018 - 2022 (USD Million)
TABLE 245. Japan cancer biological therapy market size, by blood cell growth factors, 2023 - 2032 (USD Million)
TABLE 246. Japan cancer biological therapy market size, by cytokines, 2018 - 2022 (USD Million)
TABLE 247. Japan cancer biological therapy market size, by cytokines, 2023 - 2032 (USD Million)
TABLE 248. Japan cancer biological therapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 249. Japan cancer biological therapy market size, by route of administration, 2023 - 2032, (USD Million)
TABLE 250. China cancer biological therapy market size, by product, 2018 - 2022 (USD Million)
TABLE 251. China cancer biological therapy market size, by product, 2023 - 2032, (USD Million)
TABLE 252. China cancer biological therapy market size, by MAB, 2018 - 2022 (USD Million)
TABLE 253. China cancer biological therapy market size, by MAB, 2023 - 2032 (USD Million)
TABLE 254. China cancer biological therapy market size, by vaccines, 2018 - 2022 (USD Million)
TABLE 255. China cancer biological therapy market size, by vaccines, 2023 - 2032 (USD Million)
TABLE 256. China cancer biological therapy market size, by cancer growth blockers, 2018 - 2022 (USD Million)
TABLE 257. China cancer biological therapy market size, by cancer growth blockers, 2023 - 2032 (USD Million)
TABLE 258. China cancer biological therapy market size, by blood cell growth factors, 2018 - 2022 (USD Million)
TABLE 259. China cancer biological therapy market size, by blood cell growth factors, 2023 - 2032 (USD Million)
TABLE 260. China cancer biological therapy market size, by cytokines, 2018 - 2022 (USD Million)
TABLE 261. China cancer biological therapy market size, by cytokines, 2023 - 2032 (USD Million)
TABLE 262. China cancer biological therapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 263. China cancer biological therapy market size, by route of administration, 2023 - 2032, (USD Million)
TABLE 264. India cancer biological therapy market size, by product, 2018 - 2022 (USD Million)
TABLE 265. India cancer biological therapy market size, by product, 2023 - 2032, (USD Million)
TABLE 266. India cancer biological therapy market size, by MAB, 2018 - 2022 (USD Million)
TABLE 267. India cancer biological therapy market size, by MAB, 2023 - 2032 (USD Million)
TABLE 268. India cancer biological therapy market size, by vaccines, 2018 - 2022 (USD Million)
TABLE 269. India cancer biological therapy market size, by vaccines, 2023 - 2032 (USD Million)
TABLE 270. India cancer biological therapy market size, by cancer growth blockers, 2018 - 2022 (USD Million)